Healthcare company-building profile
Accelerator for Cancer Therapeutics (ACT)
TMC Innovation, Texas Medical Center
AcceleratorHealth system acceleratorHospital or health systemActive
Source-based profile
Program at a Glance
- Program type
- Accelerator
- Program category
- Health system accelerator
- Organization
- TMC Innovation, Texas Medical Center
- Organization type
- Hospital or health system
- Location
- Houston, Texas
- Company stage served
- Research or idea stage to Early stage
- Cohort or participation model
- Annual cohort of early-stage oncology therapeutics companies and investigators
- Investment or funding offered
- Not publicly documented
- Published investment terms
- Not publicly documented
- Equity or fee model
- Not publicly documented
- Clinical or hospital connection
- Yes
- Application status
- Active
- Founded
- 2021
Public description
About the program
The Accelerator for Cancer Therapeutics is TMC Innovation's program for early-stage oncology therapeutics companies and academic investigators in Texas. Selected teams get access to TMC's clinical and research institutions, drug development expertise and investor connections. TMC has announced annual ACT classes since 2022.
What the program publicly emphasizes
Focus areas and features
OncologyTherapeuticsBiotechDrug discovery
- Category: Health system accelerator
- Program structure: Annual cohort of early-stage oncology therapeutics companies and investigators
Sources
External source links open in a new tab.